A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer
Clinical trial NCT02053636 · COMPLETED
Trial details
- NCT number
- NCT02053636
- Sponsor
- Institut de Recherches Internationales Servier
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2017-03-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.